Cargando…

SLPI Inhibits ATP-Mediated Maturation of IL-1β in Human Monocytic Leukocytes: A Novel Function of an Old Player

Interleukin-1β (IL-1β) is a potent, pro-inflammatory cytokine of the innate immune system that plays an essential role in host defense against infection. However, elevated circulating levels of IL-1β can cause life-threatening systemic inflammation. Hence, mechanisms controlling IL-1β maturation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakrzewicz, Anna, Richter, Katrin, Zakrzewicz, Dariusz, Siebers, Kathrin, Damm, Jelena, Agné, Alisa, Hecker, Andreas, McIntosh, J. Michael, Chamulitrat, Walee, Krasteva-Christ, Gabriela, Manzini, Ivan, Tikkanen, Ritva, Padberg, Winfried, Janciauskiene, Sabina, Grau, Veronika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458293/ https://www.ncbi.nlm.nih.gov/pubmed/31019507 http://dx.doi.org/10.3389/fimmu.2019.00664

Ejemplares similares

Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors
por: Siebers, Kathrin, et al.
Publicado: (2018)

Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10
por: Zakrzewicz, Anna, et al.
Publicado: (2017)

Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP-Induced Release of IL-1β by Monocytic Cells
por: Amati, Anca-Laura, et al.
Publicado: (2017)

β-Nicotinamide Adenine Dinucleotide (β-NAD) Inhibits ATP-Dependent IL-1β Release from Human Monocytic Cells
por: Hiller, Sebastian Daniel, et al.
Publicado: (2018)

Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors
por: Richter, K., et al.
Publicado: (2016)

Monocytic Tissue Transglutaminase in a Rat Model for Reversible Acute Rejection and Chronic Renal Allograft Injury
por: Zakrzewicz, Anna, et al.
Publicado: (2015)

Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts
por: Zakrzewicz, Dariusz, et al.
Publicado: (2011)

C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation
por: Richter, Katrin, et al.
Publicado: (2018)

Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes
por: Richter, Katrin, et al.
Publicado: (2023)

Knockout of the CMP–Sialic Acid Transporter SLC35A1 in Human Cell Lines Increases Transduction Efficiency of Adeno-Associated Virus 9: Implications for Gene Therapy Potency Assays
por: Banning, Antje, et al.
Publicado: (2021)

Amyloid Beta Peptide (Aβ(1-42)) Reverses the Cholinergic Control of Monocytic IL-1β Release
por: Richter, Katrin, et al.
Publicado: (2020)

Role of gp91phox Homolog Nox1 in Induction of Premalignant Spindle Phenotypes of HPV 16 E6/E7—Immortalized Human Keratinocytes
por: Chamulitrat, Walee
Publicado: (2010)

Application of alpha1-antitrypsin in a rat model of veno-arterial extracorporeal membrane oxygenation
por: Edinger, Fabian, et al.
Publicado: (2021)

Protein Arginine Methyltransferases (PRMTs): Promising Targets for the Treatment of Pulmonary Disorders
por: Zakrzewicz, Dariusz, et al.
Publicado: (2012)

Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro
por: Hollander, Camilla, et al.
Publicado: (2003)

How SLPI soothes
por: Van Epps, Heather L.
Publicado: (2005)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
por: Zakrzewicz, Dariusz, et al.
Publicado: (2009)

Multitasking Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Negative regulation of ATP-induced inflammasome activation and cytokine secretion by acute-phase proteins: A mini review
por: Richter, Katrin, et al.
Publicado: (2022)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?
por: Zakrzewicz, Anna, et al.
Publicado: (2022)

Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942
por: Zakrzewicz, Anna, et al.
Publicado: (2022)

Study designs to investigate Nox1 acceleration of neoplastic progression in immortalized human epithelial cells by selection of differentiation resistant cells()
por: Sattayakhom, Apsorn, et al.
Publicado: (2013)

Rescue of Hepatic Phospholipid Remodeling Defect in iPLA(2)β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver
por: Chamulitrat, Walee, et al.
Publicado: (2020)

Phosphocholine-Modified Lipooligosaccharides of Haemophilus influenzae Inhibit ATP-Induced IL-1β Release by Pulmonary Epithelial Cells
por: Richter, Katrin, et al.
Publicado: (2018)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Cementoin–SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI
por: Maffía, Paulo C., et al.
Publicado: (2018)

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate
por: Baranger, Kévin, et al.
Publicado: (2011)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
por: Kongpol, Kantapich, et al.
Publicado: (2019)

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

SLPI: a new target for stopping metastasis
por: Munn, Lance L., et al.
Publicado: (2018)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2014)

iPLA2β-Null Mice Show HCC Protection by an Induction of Cell-Cycle Arrest after Diethylnitrosamine Treatment
por: Andrade, Adriana, et al.
Publicado: (2022)

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT
por: Wei, Zhijiang, et al.
Publicado: (2020)

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2021)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

Deficiency of iPLA(2)β Primes Immune Cells for Proinflammation: Potential Involvement in Age-Related Mesenteric Lymph Node Lymphoma
por: Inhoffen, Johannes, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4uo72qbmhb52vrjoollsscvte6